aero digestive tract with polymicrobial commensal flora and pathogens, in health and disease. Here, we describe the kinetics of IL10 intracellular expression and compare it with that of cytokines known to be produced by tonsillar B cells. Additionally, we detected a relevant proportion of IL17-expressing tonsillar B cells, which has not previously been reported. We immunophenotyped tonsillar IL10-expressing B cells (B10) and observed IL10 production in activated B cells at every developmental stage. Finally, we identified a relationship between decreased B10 percentages, increased proportion of the germinal centre (GC) population and hypertrophied tonsils (HT). Our findings provide greater insight into the role of B10 in GC reactions and characterized their involvement in the pathogenesis of tonsillar dysfunction.
The comprehension of unconventional immune functions of tonsillar B cells, their role in tolerance induction and protective immune responses, is crucial to unveil the dynamic interactions of the upper
aero digestive tract with polymicrobial commensal flora and pathogens, in health and disease. Here, we describe the kinetics of IL10 intracellular expression and compare it with that of cytokines known to be produced by tonsillar B cells. Additionally, we detected a relevant proportion of IL17-expressing tonsillar B cells, which has not previously been reported. We immunophenotyped tonsillar IL10-expressing B cells (B10) and observed IL10 production in activated B cells at every developmental stage. Finally, we identified a relationship between decreased B10 percentages, increased proportion of the germinal centre (GC) population and hypertrophied tonsils (HT). Our findings provide greater insight into the role of B10 in GC reactions and characterized their involvement in the pathogenesis of tonsillar dysfunction.
Tonsils are the first sites where microbial and environmental antigens (Ags) entering through the upper aero digestive tract, are managed in the human body. Suitably located at the entrance of the pharynx to grant immunologic protection, tonsils are continually exposed to dietary and airborne Ags. While lymph nodes depend on antigenic delivery through afferent lymphatics, tonsils have Ag-retaining crypts that increase their surface and enable the direct transport of the Ags deposited there, a feature that favours Ag presentation to lymphoid cells on the interior. These lymphoid cells are predominantly B cells (55% ± 15% of all tonsillar lymphocytes, depending on age). B cell receptor (BCR) engagement by Ags followed by cognate T follicular cell help (Tfh) drives the proliferation of Ag-specific naive B cells in germinal centres (GCs). GCs are microenvironments within secondary lymphoid tissues (i.e., tonsils) that are critical for memory B cell and plasma cell generation 1 . Therefore, the tonsils are sites of increased expansion of B cell diversity and memory 2 . However, tonsillectomy is indicated for patients with a history of recurrent or chronic tonsillitis (RT) or for those with obstructive symptoms from tonsillar hypertrophy (HT, no history of recurrent infections in the case of the samples in the present, unless indicated otherwise) 3 . The pathogenesis of these conditions remains largely unknown. Thus, human tonsils are unique inductive immune sites for B cell responses, provided that these organs operate properly.
Such responses are not restricted to antibody production and Ag presentation. B cell-derived cytokines are crucial for multiple aspects of immunity 4 , and new B cell subpopulations have consequently been identified. For example, a subset of B cells that produce the anti-inflammatory cytokine IL10, designated Bregs by Mizoguchi 5 , has been reported in mice and humans. In humans, multiple studies have shown that these cells are either numerically or functionally deficient in several diseases [6] [7] [8] [9] [10] [11] and are also related to renal transplant tolerance 12 . More recently, B cells have also been demonstrated as a source of the pro-inflammatory cytokine IL17 -which was initially thought to be exclusively secreted by Th17 cells-in a murine model 13 and in human PBMCs 14 .
1 Tonsillar immune actions (anti-and pro-inflammatory) must be tightly regulated to balance the protection against virulent germs and the tolerance to harmless flora and innocuous Ags in the oropharynx. We proposed that because tonsils are B cell organs, the B10 population plays a role in such regulation. Despite the relevance of the issue in light of the importance gained by the mucosal route of vaccine administration, tonsillar B10 has not yet been fully characterized.
In the present study, we determined the phenotype of tonsillar B10, analysed the kinetics of IL10 intracellular expression and compared these results with those of other cytokines produced by tonsillar B cells. Notably, this study is the first to report a relevant proportion of IL17-expressing tonsillar B cells. Finally, we discuss the physiological relevance of B10 in vivo, as samples donated from HT patients presented a lower proportion of B10 and a higher fraction of GC than samples donated from RT patients.
Results and Discussion
Characterization of IL10 production by B cells from human tonsils. Co-treatment with CpG and CD40L is a potent method of inducing IL10 production by circulating B cells, peaking at 72 hours hs post stimulation 15 . As tonsillar B cells express high levels of TLR9 16 , we used this approach to examine their production of IL10 at the single cell level using FACS. IL2 and IL4 were also added to the culture, as they promote the survival of all B cell subsets 17 . The cells that were already dead prior to permeabilization were excluded from the analysis based on their forward-and side-light scatter properties (P1, Fig. 1a ), as we confirmed that the fixation procedure utilized appropriately preserved the cell morphology. Such scatter-based assay for distinguishing the viability of untransformed human B cells showed consistency with the results obtained from FITC-annexin staining 18, 19 . We previously confirmed the results using dead cell staining and showed that dead cell discrimination by forward/ side scatter presented excellent consistency with the results obtained using 7 amino-actinomycin D (7AAD) staining specifically for tonsillar B cells 17 . We observed a substantial production of IL10 (Fig. 1a ). Tonsillar and circulating B cell subsets exhibit differences with respect to the kinetics of activation 17 ; therefore, we replicated the assay at earlier time points. We observed a trend similar to that reported for circulating B cells 6, 7, 20 . While the proportion of tonsillar B10 steadily increased between 16 and 72 hs in all cases ( Fig. 1b and e) , the proportion of B10 detected at the different time points varied between donors and the cause of each surgery, an issue that will be addressed in the following sections. As a control for the appropriate stimulation of tonsillar B cells, we also measured IL6 and IL8 expression, as these are cytokines with faster release kinetics than IL10 16 . We confirmed that tonsillar B cell cultures readily produced other cytokines at early time points at which IL10 was barely detected (Fig. 1c, d and e). We concluded that comparable signals induce circulating B10 and tonsillar B10 to express IL10 in vitro in a similar fashion in terms of kinetics and overall percentage.
Notably, unlike IL10, in some cases, significant levels of IL6 and IL8 could be detected at the single cell level without CpG/CD40L stimulation (at 0 hs, ~8.5% and ~7.5%, respectively, for the patient shown in Fig. 1c and d ), confirming our previous reports in relation to the capacity of tonsillar B cells to promptly produce good amounts of such cytokines on a per cell basis, reflecting their adaptation to a strong and immediate inflammatory response on site 17 . At 16 hs post stimulation, ~17% of the tonsillar B cell population had become IL6-secreting cells, ~8% had become IL8-secreting cells, and ~2.5% represented the B10 population. At the following time point, 32 hs post stimulation, more than one-third of B cells in culture produced IL6, whereas ~12% of B cells exhibited intracellular IL8, and IL10 could be detected in ~4% of B cells. Finally, at 72 hs post stimulation, approximately ~2% of the B cells in culture expressed either IL6 or IL8. Thus, in terms of the relative kinetics of production, these findings were consistent with those of Gantner F. et al. 15 using an alternative method to measure cytokines and further confirmed the ability of B cells to secrete pro and anti-inflammatory cytokines, as recently reviewed by Shen and Fillatreau 4 . With regard to the percentage of IL6-and IL8-secreting cells at different time points, the results varied across individuals; therefore, we showed the contour plots of a single patient and graph lines plotting the results of 5 different patients for the cytokine kinetics. Further work into recruiting more patients is required to perform meaningful statistics and accurately elucidate putative associations between the proportions and levels of pro-inflammatory cytokine expression and causes of surgery, as described below for IL10.
Importantly, we also observed that tonsillar B cells produced considerable amounts of IL17 (Fig. 2) . IL17 secretion by T cells (Th17) has been implicated in defence against extracellular pathogens and the pathogenesis of inflammatory diseases. As tonsillectomy generally indicates the chronic inflammation of tonsils due to RT and/or HT, our observation seems logical. While Th17 cells have been the subject of multiple studies, reports on the secretion of IL17 by B cells are scarce 13, 14 . Hence, these results complement the reports of previous studies, extending such capacity to B cell rankings in the human mucosal immunology system. When we analysed the kinetics, IL17 secretion from tonsillar B cells peaked upon 32 hs of CpG and CD40L stimulation.
It was not feasible to detect whether B10 co-expressed any of these pro inflammatory cytokines, as intracellular cytokine levels at the 72 hs time point were quite low for the whole culture. Moreover, as evidenced in Figs 1 and 2a, this late time point was particularly affected by the down-modulation of surface CD20 in response to different stimuli, and this effect has been extensively described previously 21, 22 . As the present study is the first report on tonsillar IL17-expressing B cells and their progress in time, we seek to improve such determination at 72 hs by excluding CD3 + cells as likely contaminants when CD20 expression is lost (Fig. 2b) . Finally, we supplemented cultures with just IL2 and IL4, which prolong cell survival with minimal stimulation, thus circumventing CD20 downregulation and confirming IL17 expression by tonsillar B cells under those conditions (Fig. 2c) .
Collectively, these results demonstrated that despite disease-associated changes, such as RT and HT, B cells from those damaged tonsils preserve their immune competence to secrete a number of cytokines. Considering that B cells comprise the majority of tonsillar lymphocytes 17 , an understanding of the relative levels of the different cytokine expressing B cell subsets and their association with tonsillar pathology and oral microbiome certainly requires further investigation. Importantly, a comprehensive picture of the effect of B cell cytokines on nearby cells and their microenvironment may inform new therapies for paediatric patients. Phenotype of IL-10-competent tonsillar B cells. The better understood and most studied regulatory mechanism of B cells is mediated by IL10; therefore circulating human B10 had been exhaustively phenotyped 6, 7, 19 . Considering the critical role that tissue environment imprints on the different immune cellular subsets, we characterized tonsillar B10. We performed a multiparametric FACS assay on tonsillar B cells to analyse the expression of numerous cell surface markers previously associated with an IL10-secreting profile in B cells isolated from PBMCs. Compared with their IL10 -B cell counterparts, tonsillar B10 expressed statistically significant higher levels of CD24, CD27, CD38, CD39, PDL1, CD25, CD1d, CD5, and CD21, consistent with the observations previously published for circulating B10 under similar conditions (Fig. 3a) and extensively reviewed in ref. 23 . However, B10 did not significantly differ from IL10 -B cells in terms of the expression of CD73, CD62L and IgD (Fig. 3a) , the latter presenting bimodal expression for both populations in all cases. 
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+/− (memory cells). To further evaluate where the B10 subset would fall under such classification scheme, we stimulated the cells for a shorter period of time (16 hs), as such brief stimulation is adequate for B10 to produce IL10 without inducing changes in the overall phenotype of the CD20 + culture. We detected B10 within the Bm2, Bm2′, Bm3, Bm4 eBm5 and Bm5 subsets (Fig. 3b) . The present study is not the first to report that B10 are diffusely scattered throughout the B cell lineage. According to previous reports, B10 could be present within the IgM memory 10 , GC-derived plasmablast 11 , and immature transitional 6, 10 compartments. In fact, whether the immature transitional compartment effectively contains B10 remains controversial 25 . As previously indicated by Iwata and colleagues 7 , we confirmed (data not shown) that B10 do not express CD10 at the high levels required for classification as immature precursors. Through the CD10 staining, we could distinguish between pre-GC cells and transitional B cells. Therefore, we can ascertain that tonsillar B10 are pre-GC cells, indicating prior Ag stimulation. In any case, this plethora of phenotypes can only be plausible if B10 cells experience the entire differentiation programme once activated, secreting IL10 at every developmental stage, suggesting that these cells are pre-destined for this function, i.e., these cells comprise a separate lineage.
Hypertrophied tonsils with intensively active germinal centres are characterized by a reduced B10 population compared with tonsils excised as a result of recurrent tonsillitis. As previously mentioned, the samples donated for the present study were derived from several diseases: RT, HT (no history of recurrent infections), and eventually, HT combined with RT ( Table 1 ). The differences in the pathologies that led to surgery were useful to assess the physiological relevance of tonsillar B10. We only received 2 samples from patients with HT combined with RT; thus, a relevant statistical analysis with that group was not feasible, and we showed the results from these patients but limited the discussion to the groups that included a majority of patients, granting statistical relevance to the observations. For the patients listed in Table 1 , we scored the percentages of B10 following the gating strategy depicted in Supplementary Fig. S1 . As we used cell shape to distinguish dead/live cells as opposed to using a more reliable fixable viability dye, we cannot rule out contaminating dead cells in the P1 gate, which could non-specifically bind anti-IL10. The isotype control (see Supplementary  Fig. S1 ) evidenced that such fraction accounted for less than 0.5% of the cells. Interestingly, HT tonsils accounted for samples with a significantly lower percentage of B10 cells compared to those from RT (Fig. 4a , p < 0.005) and presented a significantly higher proportion of the GC population (Bm3 and Bm4, Fig. 4b ; p < 0.005 Fig. 4c ) than those from children with RT. Such comparative increment of the GC percentage was not accompanied by a proportional growth of the memory B cell population in those HT samples. In contrast, these samples displayed a significantly lower percentage of the eBm5 subset than RT samples ( Fig. 4b ; p < 0.005 Fig. 4c ), indicative of a putative blockade between the GC and memory B cell stages on HT patients. This finding is consistent with the results of a previous report 26 , in which the authors compared histological cross sections of the surgical samples from HT and RT patients. Notably, they found that the number of GCs is the only histopathological criterion that can be used to differentiate the samples from the two groups. In this context, Achouret al. 27 recently demonstrated a role for tonsillar B10 in controlling the functions of Tfh cells. The results of the present study extended these findings, uncovering a correlation in vivo, as lower the proportion of B10 implied the deficient suppression of Tfh functions and a consequent failure to repress the GC reactions, as observed in the HT samples. Moreover, using FACS and immunohistochemistry, Yamashita and colleagues showed increased the number of Tfh cells in HT tonsillar samples compared with RT samples 28 . Taken together, these findings also support the notion that B10 are indeed a committed functional lineage, as a blockage in the differentiation of these cells affects the proportion of the entire subset.
As it is long established that regulatory T cells (Tregs) are essential to tolerance 29, 30 , there have been studies characterizing tonsillar Tregs 31, 32 . However, tonsils are essentially B cell organs, which turn them in an excellent and novel model to study inflammatory and regulatory immune mechanisms from a human B cell perspective. In conclusion, we characterized IL10 secretion by tonsillar B cells, and the results contributed to a comprehensive picture of the cytokine-secreting B cell population in tonsils. The results suggest a role for the B10 population as a distinct lineage in the pathophysiology of HT. We provided evidence that defective B10 compartment indicates an increase in the proportion of GC, suggesting unrestrained Tfh function. Further mechanistic studies will define the accurate role of the B10 population. This study advances our understanding of the immune functions of the tonsils, a subject that has gained momentum not only in light of interests in the nasal route for vaccine administration to stimulate both mucosal and systemic immunity but also considering the prevalence of tonsillar diseases in childhood. Table 1 ). The proportion of B10 was determined using FACS, and TMC were stained for surface CD20, CD3 and intracellular IL10 after culture for 72 hs in the presence of CpG+CD40L+IL2+IL4, followed by stimulationwith PMA/ionomycin/Brefeldin A for the last 5 hs. (b) Dot plot depicting the percentage of the tonsillar B cell subsets for the 3 groups of patients (a selected individual for RT; HT; HT+RT). Fresh TMC were stained for CD20, IgD, and CD38 for the patients detailed in 3a. Arrows and percentages indicate frequencies of GC and early memory B cell populations. (c) The data show the mean percentage of the frequencies of GC and early memory ± S.D pooled from independent experiments performed with tonsils from the same 12 individuals detailed in 3a. Statistical analysis of the results in 3a and 3c was performed using unpaired Student's t test**p < 0.005.
